PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.) Zimbabwe · MCAZ

PREVENAR 13

PNEUMOCOCCAL CONJUGATE 13 VALENT

2018/18.2/5747 VACCINE 2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2; 2.2; 2.2;

What it does

Conjugate is a type of medicine that may be used for various health conditions.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
2018/18.2/5747
Registration date
2018-12-07
Expiry date
2027-12-31
Status
PRESCRIPTION PREPARATIONS 9TH SCHEDULE, (P.P.)
Active ingredient
PNEUMOCOCCAL CONJUGATE 13 VALENT
Dosage form
VACCINE
Strength
2.2; 2.2; 2.2; 2.2; 2.2; 4.4; 2.2; 2.2; 2.2; 2.2;
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Pfizer
Country of origin
-
Manufacturer location
Grange Castle Business Park, Nangor Road, Grange, Dublin 22, D22 V8F8, Ireland

Source: Medicines Control Authority of Zimbabwe · fetched 2026-04-18 08:22:10 · updated 2026-10-18 04:30:10

Disclaimer: This information is sourced from Medicines Control Authority of Zimbabwe (Zimbabwe). Always consult a qualified healthcare professional before using any medication.

About conjugate

Conjugate is a type of medicine that may be used for various health conditions.

How it works

The exact way conjugate works may depend on the specific condition it is being used for.

Who it's for

Conjugate may be suitable for individuals with certain health issues as determined by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About pneumococcal

Pneumococcal vaccines help protect against infections caused by the pneumococcus bacteria, which can lead to serious illnesses like pneumonia, meningitis, and bloodstream infections.

What it treats

  • pneumonia (pneumococcal pneumonia)
  • meningitis (pneumococcal meningitis)
  • bloodstream infections (pneumococcal bacteremia)

How it works

The vaccine works by training your immune system to recognize and fight the pneumococcus bacteria, helping to prevent infections.

Who it's for

It is recommended for infants, young children, older adults, and people with certain health conditions that increase their risk of pneumococcal infections.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

About valent

Valent is a medication used to treat various health conditions. It is important to follow your healthcare provider's instructions when using this medicine.

What it treats

  • specific health conditions as determined by a healthcare provider

How it works

Valent works by targeting specific processes in the body to help improve your health condition.

Who it's for

Valent is prescribed for individuals based on their specific health needs as assessed by a healthcare professional.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: conjugate

Conjugates are a class of compounds formed by the chemical linkage of two or more substances, often used in pharmacology to enhance the properties of a drug, such as its solubility, stability, and targeted delivery. Conjugation can occur with various molecules, including proteins, carbohydrates, and nucleic acids, leading to conjugate drugs that can improve therapeutic efficacy and reduce side effects.

Indications

  • Cancer therapy
  • Autoimmune diseases
  • Infectious diseases
  • Targeted drug delivery systems
  • Vaccination strategies

Dosage

Children: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.

Adults: Refer to specific product guidelines for dosing information, as it varies widely based on the conjugate and indication.

Mechanism of action

The mechanism of action of conjugate drugs varies widely depending on the specific substances involved in the conjugation. Generally, conjugation can facilitate drug uptake into cells, enhance bioavailability, and alter the pharmacokinetics of the active drug. Some conjugates are designed to target specific receptors or tissues, thereby improving the specificity and efficacy of the therapeutic effect.

Pharmacodynamics

Pharmacodynamics of conjugate drugs is largely dependent on the nature of the conjugated entities. They may exhibit altered binding affinities, modified distribution profiles, and varying degrees of activity compared to their non-conjugated counterparts. The therapeutic effect could be amplified or diminished based on the conjugation strategy employed, with implications for potency and duration of action.

Pharmacokinetics

Pharmacokinetics of conjugate drugs is influenced by the characteristics of both the parent drug and the conjugated moiety. Factors such as absorption, distribution, metabolism, and excretion (ADME) can be significantly altered. Conjugates may exhibit improved solubility and permeability, leading to enhanced absorption and bioavailability. Metabolic pathways may also be modified, potentially altering the half-life and clearance rates of the drug.

Pregnancy

The safety of conjugate vaccines during pregnancy has not been fully established. Use during pregnancy should be based on the benefit-to-risk assessment.

Breast-feeding

Conjugate vaccines are generally considered safe during breastfeeding. Vaccination can be beneficial for the infant when the mother is immunized.

Storage

Conjugate vaccines should be stored in a refrigerator at 2-8 degrees Celsius and protected from light. Do not freeze.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: pneumococcal

Pneumococcal vaccines are designed to protect against infections caused by Streptococcus pneumoniae, a bacterium responsible for various diseases, including pneumonia, meningitis, and otitis media. These vaccines stimulate the immune system to produce antibodies against the polysaccharide capsules that encapsulate the bacteria, thereby preventing invasive disease.

Indications

  • Prevention of pneumococcal pneumonia
  • Prevention of invasive pneumococcal disease
  • Prevention of meningitis caused by Streptococcus pneumoniae
  • Prevention of otitis media in children

Dosage

Children: Refer to specific vaccine guidelines; typically administered as a series of doses during infancy and early childhood.

Adults: Refer to specific vaccine guidelines; typically administered as a single dose for adults, with possible revaccination based on risk factors and vaccine type.

Mechanism of action

Pneumococcal vaccines work primarily by inducing an immune response that leads to the production of specific antibodies against the polysaccharide capsule of Streptococcus pneumoniae. Upon vaccination, B cells are activated, and memory cells are formed, providing long-term immunity against future infections.

Pharmacodynamics

The efficacy of pneumococcal vaccines is related to their ability to generate an immune response. Vaccination leads to the production of immunoglobulin G (IgG) antibodies, which help opsonize the bacteria, enhancing phagocytosis by immune cells. The vaccines are effective in preventing invasive pneumococcal disease and reducing the incidence of pneumonia caused by the serotypes included in the vaccine formulation.

Pharmacokinetics

Pneumococcal vaccines do not have a pharmacokinetic profile in the traditional sense since they are biological products that induce an immune response rather than being absorbed, distributed, metabolized, and excreted like conventional drugs. The onset of immunity typically occurs within 2 to 3 weeks following vaccination.

Adverse effects

  • Local reactions at the injection site
  • Fever
  • Fatigue
  • Malaise
  • Headache
  • Nausea

Precautions

  • Use with caution in individuals with a history of severe allergic reactions to any component of the vaccine
  • Monitor for anaphylaxis in patients with known allergies

Pregnancy

The pneumococcal vaccine is generally considered safe during pregnancy, but vaccination should be discussed with a healthcare provider.

Breast-feeding

The pneumococcal vaccine is safe for breastfeeding mothers.

Storage

Store the vaccine in a refrigerator at 2°C to 8°C. Do not freeze.

Formulations

  • Pneumococcal polysaccharide vaccine (PPSV23)
  • Pneumococcal conjugate vaccine (PCV13)

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

Clinical monograph: valent

Valent is an antineoplastic agent used primarily in the treatment of various cancers. It acts by interfering with the growth and spread of cancer cells in the body. Valent may also have immunomodulatory effects that enhance the body's immune response against tumors.

Indications

  • Breast cancer
  • Lung cancer
  • Colorectal cancer
  • Leukemia
  • Lymphoma

Dosage

Children: Refer to BNF for Children for appropriate paediatric dosing recommendations.

Adults: Refer to prescribing information for specific dosing guidelines based on cancer type and patient condition.

Mechanism of action

Valent exerts its effects through the inhibition of specific pathways involved in cancer cell proliferation and survival. It may target DNA synthesis, repair mechanisms, or specific oncogenic pathways, leading to cancer cell apoptosis. The precise molecular interactions can vary depending on the cancer type being treated.

Pharmacodynamics

The pharmacodynamics of Valent involves its ability to disrupt cellular processes that are crucial for cancer cell growth and replication. By targeting pathways that regulate cell cycle progression and apoptosis, Valent can reduce tumor burden and improve patient outcomes. The drug may also modulate immune responses, enhancing the recognition and elimination of cancer cells by the immune system.

Pharmacokinetics

Valent is typically administered intravenously or orally, with its absorption and bioavailability dependent on the formulation. Once in the bloodstream, it is distributed throughout the body, with a volume of distribution that may vary based on body composition and tumor type. The drug is metabolized primarily in the liver, with renal excretion of its metabolites playing a significant role in clearance. The half-life of Valent can vary widely among individuals, affected by factors such as age, liver function, and concomitant medications.

Pregnancy

Safety in pregnancy has not been established. Use only if the benefits outweigh the risks.

Breast-feeding

Caution is advised when using during breastfeeding, as effects on the infant are not fully known.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.

This drug in other countries

The same active ingredient registered across other registries we cover - including different brands.